Download press release in English version
Medotech has launched the first and only product for treatment of bruxism (teeth grinding), which is a serious problem for more than 5 million people in Europe, US and Japan. The product is based on advanced software code on a chip incorporated with other technologies. The result is a significant reduction or elimination in the patient’s propensity to grind, after only 3-5 weeks use. The investment round of 30 million will be used for product launch in Europe in 2009 and in the US in 2010. For further information, please visit Medotech’s website.
About Via Venture Partners
Via Venture Partners is a Nordic venture capital fund that invests in Nordic IT companies with international growth potential. The fund manages 1 billion Danish kronor and is owned by ATP, Denmark’s largest pension fund. Since its launch in 2006, Via Venture Partners has invested in 16 companies in Denmark, Sweden, Norway and Finland.
For more information, please contact:
Peter Thorlund Haahr, Via Venture Partners, +45 28 10 17 95, pth@viaventurepartners.com